Abstract: Acquired immunodeficiency syndrome (AIDS) is one of the most important public health problems, affecting many people every day. This syndrome is caused by the human immunodeficiency virus (HIV) and the HIV-1 protease plays an essential role by promoting virus maturation and thus infecting new cells. The HIV-1 protease is one of the main targets for anti-HIV drug therapy. The present work is a literature survey of plant extracts whose activity has been studied on HIV-1 protease. Here we list 275 species of medicinal plants, distributed in 99 families, with their place of origin, part used, type of extract, concentration and activity. We aim with this work to provide data that could be used in the research and development of new therapeutic agents for AIDS treatment.
INTRODUCTION
Acquired immunodeficiency syndrome (AIDS) is one of the most important public health problems now a day. At the end of 2007, about 33 million people were estimated to be infected and 25 million individuals have died from this disease [1] . Every day, over 6800 people become infected with the human immunodeficiency virus (HIV), the causative agent of AIDS, and over 5700 people die from AIDS, mostly because of inadequate access to HIV prevention and treatment services. In addition, HIV infected people are affected by emotional, behavioural, and psychosocial complications [2, 3] .
In regard to HIV biology, the virus interacts with target cells using envelope glycoproteins that are recognized by CD4 receptors and CCR5 (macrophage) or CXCR4 (T cell) co-receptors leading to membrane fusion followed by virus entry and subsequent integration to the host genome [1] . The HIV-1 protease is a member of the aspartyl-protease family that performs an essential step in the life cycle of the virus by promoting the maturation of the envelope proteins from cleaved precursors. Therefore the inhibition of this enzyme produces immature and non-infectious virions [4] [5] [6] .
Because of its fundamental importance on virus biology, HIV-1 protease has emerged as one of the main targets for anti-HIV drug therapy. HIV-1 protease inhibitors have been successfully used on AIDS therapy. However, the development of drug resistance by the virus represents an important problem on AIDS-chemotherapy. Additionally, there is not yet a definitive cure for this disease [7] .
Thus, the search for new anti-HIV effective therapies remains a challenge for the scientists. Therefore around the *Address correspondence to this author at the Departamento de Fisiologia e Patologia -DFP, Laboratório de Tecnologia Farmacêutica -LTF, Universidade Federal da Paraíba -UFPB, Cx. Postal 5009, CEP: 58051-970, João Pessoa, PB, Brazil; Tel: 83 32167003; Fax: +55 83 32167502; E-mail: mrpiuvezam@ltf.ufpb.br world many researches have focused on natural products as a source of structurally novel chemicals. Medicinal plants are characterized by the presence of several bioactive constituents and research with plants and natural products may provide new compounds for anti-HIV drug therapy [8] .
Several reports have shown the action of medicinal plants and its constituents against various diseases such as: allergy [9, 10] , cancer [11] , pain [12] , malaria [13] , osteoporosis [14] , Parkinson's disease [15] , leishmania [16] , hyperglycemia [17] , inflammation [18] , fungal and bacterial infection [19] , hypertension [20] , diabetes [21] , obesity [22] and ulcer [23] . Here, we reviewed the literature related to plants with anti HIV-protease activity.
MATERIALS AND METHODS
The search was carried out on PubMed, Biological Abstracts and NAPRALERT (acronym for Natural Products ALERT -the data bank of the University of Illinois at Chicago) updated until November 2009, using ''HIVprotease'' as legend. Plants extract with complete information (place, part used, type of extract, concentration and activity) were selected for this work. The references found in the search were later consulted for details on the models or mechanism-based bioassays used for testing the plant extracts against HIV-1 protease.
RESULTS AND DISCUSSION
As result for our search we list 275 species of medicinal plants studied, which were distributed in 99 families, including Asteraceae, Fabaceae, Rosaceae and Lamiaceae with 33, 19, 20 and 11 plants, respectively. Hence 205 of the plants studied, showed some degree of activity depending on the part used, the type of extract and the concentration on which they were used. About 70 species were inactive against HIV-1 protease enzyme. Based on this search it was also possible to classify the effect of the extracts as active, strongly active, weakly active or inactive ( Table 1) . Most of protease assays were carried out based on the cleavage of a peptide substrate, to simulate a natural processing site between the matrix and capsid polypeptides of gag precursor for HIV-1 protease. Enzymes and substrates reacted over appropriated conditions such as temperature, pH, and medium. After reaction the hydrolysate and remained substrate were quantified and analyzed by HPLC or fluorogenic assay [24] [25] [26] .
Plants were studied mainly in countries of Asia (China, Japan, Indonesia, India, South Korea and Singapore) and a few in America (Panama), Africa (Egypt and Sudan) and Oceania (New Zealand). Many of these countries are known by their traditional medicine, which made them attractive for search of natural products with anti-HIV activity [27] [28] [29] .
In searching for natural products with anti-HIV properties, Xu et al. [24] selected and examined typical traditional medicines from China, Japan and Indonesia for possible inhibitory activity of their aqueous extracts against HIV-1 protease, and as result over 77% of them were active in the tests performed. One interesting observation was that different species of plant within a genus can vary in their effects, e.g. within the Magnolia genus, M. fargesii was active against HIV-1 protease, whereas M. obovata and M. oficinalis were not. Among Terminalia species, T. arjuna and T. chebula were active while T. belerica was inactive, indicating that inhibitors of HIV-1 protease are quite widely distributed among various crude extract of plants. Although T. arjuna was active at concentration of 250 μg/ml, at 25 μg/ml it was not, confirming that a plant can or cannot show activity depending on the concentration of the extract.
Aqueous extracts of most crude drugs are likely to contain many phenolic compounds and tannins. Some plants, such as Geum japonicum, Punica granatum, Rhus javanica, T. arjuna, T. chebula, Woodwardia orientalis and W. unigemmata have been reported to contain tannins and other phenolic compounds which have known antiviral properties and thus may be responsible for the activity of these plants [30] [31] [32] [33] [34] .
Hussein et al. [26] investigated for the first time plants used in the folk medicine in Sudan targeting their inhibitory effects on HIV-1 replication and HIV-1 protease enzyme. Although these plants had never been investigated for their antiviral activity, 19 extracts showed inhibitory effects on the viral replication and 5 extracts showed considerable inhibitory effects against HIV-1 protease. The antiviral effect of the other plants may reflect an inhibitory activity on enzymes other than the protease or through inhibition of other essential steps in the viral life cycle. The authors also found that phenolic compounds isolated from Maytenus senegalensis, especially those glycosylated showed inhibitory activity, suggesting that the glucose moiety may have a potentiating effect on the activity of these compounds against HIV-1 protease enzyme.
India is known for Ayurvedic traditional medicine and it is used by several people in the world to treat various diseases. In view of its importance in therapy, Kusumoto et al. [35] made a screening of the inhibitory effects of plants used in Ayurveda on HIV-1 protease. Plants as Areca catechu, Eugenia jambolana, Saraca indica and Terminalia arjuna inhibited the HIV-1 protease activity by more than 70% at a concentration of 0.2 mg/ml. A. catechu showed the most potent inhibition and its isolated procyanidin arecatannin B1 is one of the compounds possibly responsible for the inhibitory activity of this plant.
Despite the great biodiversity of the American continent, we only found one plant studied. Cordia spinescens (Boraginaceae) used in Central America to relieve fever and headache [36] . A leave extract of this plant presented potential protease inhibition [37] . The magnesium lithospermate, calcium rosmarinate and magnesium rosmarinate compounds were isolated and identified as potent reverse transcriptase inhibitors. However, these compounds showed weak protease activity, indicating that substances bearing a protease inhibitory effect still remained in the fractions and need to be isolated and tested [38] .
A screening of New Zealand plant extracts for inhibitory activity against HIV-1 protease was made for Wan et al. [29] . Pseudotsuga menziesii was one of the active plants and a polyphenol compound was the causative compound for the inhibitory activity. These data demonstrated once more the importance of this class of metabolites on HIV-1 protease inhibition.
New studies are being made now a day. Several reports have identified plants and isolated compounds as potential inhibitors of the enzyme HIV-1 protease [39] [40] [41] [42] [43] [44] . In this article we reviewed the studies of many plant extracts able to inhibit the HIV-1 protease, some of which presented strong activity. In addition, phenolic compounds isolated from some of the studied plants also showed to be active, which emphasizes the importance of isolating and testing new structures on HIV-1 protease. Thus, research with natural products may provide new therapeutic agents for AIDS treatment.
